Every two years, the well-known Swiss publication Bilan publishes the “Technology by Bilan” supplement. For this edition, Gilles Pfend, European & Swiss Patent Attorney and Partner at Katzarov, writes about the plausibility in patenting Life Sciences inventions. “There is a risk when filing a patent application for an invention for which little or no experimental […]